Treatment of phobic anxiety and psychogenic impotence by systematic desensitization employing methohexitone-induced relaxation.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001007:Anxiety / Q000628:therapy*; D001521:Behavior Therapy; D007172:Erectile Dysfunction / Q000628:therapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007490:Iproniazid / Q000627:therapeutic use; D008297:Male; D008723:Methohexital / Q000627:therapeutic use*; D008875:Middle Aged; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D010698:Phobic Disorders / Q000628:therapy*; D011613:Psychotherapy; D012063:Relaxation
D008996:Monoamine Oxidase Inhibitors; D007490:Iproniazid; D008723:Methohexital